BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3747335)

  • 1. Adult-onset minimal change nephrotic syndrome: a long-term follow-up.
    Nolasco F; Cameron JS; Heywood EF; Hicks J; Ogg C; Williams DG
    Kidney Int; 1986 Jun; 29(6):1215-23. PubMed ID: 3747335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset nephrotic syndrome with minimal changes: response to corticosteroids and cyclophosphamide.
    Nolasco F; Cameron JS; Hicks J; Ogg CS; Williams DG
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():588-93. PubMed ID: 3991549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment aspects of primary nephrotic syndrome in adults.
    Rasić S; Uncanin S; Dzemidzić J; Aganović K; Srna A; Rasić I
    Bosn J Basic Med Sci; 2006 May; 6(2):16-20. PubMed ID: 16879107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
    Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
    Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse.
    Fujimoto S; Yamamoto Y; Hisanaga S; Morita S; Eto T; Tanaka K
    Am J Kidney Dis; 1991 Jun; 17(6):687-92. PubMed ID: 2042651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late resistance to corticosteroids in nephrotic syndrome.
    Srivastava RN; Agarwal RK; Moudgil A; Bhuyan UN
    J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C; Melvin T; Kim Y
    Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of nephrotic syndrome in childhood.
    Melvin T; Bennett W
    Drugs; 1991 Jul; 42(1):30-51. PubMed ID: 1718684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
    Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
    Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP; Stapleton FB; Roy S; Wyatt RJ
    Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.
    Ueda N; Kuno K; Ito S
    Arch Dis Child; 1990 Oct; 65(10):1147-50. PubMed ID: 2248508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history and response to treatment of minimal change nephrotic syndrome.
    Prabhakar KS; Prakash KC; Mani MK
    J Assoc Physicians India; 1993 May; 41(5):263-5. PubMed ID: 8300454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and renal function in minimal change nephrotic syndrome.
    Bohlin AB
    Acta Paediatr Scand; 1984 Sep; 73(5):631-6. PubMed ID: 6485782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal function in subjects with minimal change steroid-responsive nephrotic syndrome in childhood].
    Strzelecka-Lichota A
    Ann Acad Med Stetin; 2004; 50(2):41-9. PubMed ID: 16529164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
    Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
    Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.